Zachary S Wallace
Overview
Explore the profile of Zachary S Wallace including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
188
Citations
5489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel N, Srivatsan S, Kowalski E, King A, Wang X, Vanni K, et al.
RMD Open
. 2025 Mar;
11(1).
PMID: 40044572
Objective: To investigate the risk factors for severe acute COVID-19 outcomes in the Omicron era among individuals with systemic autoimmune rheumatic diseases (SARDs). Methods: We identified patients with confirmed SARDs...
2.
McDermott G, Gill R, Byrne S, Gagne S, Wang X, Paudel M, et al.
medRxiv
. 2025 Feb;
PMID: 39974108
Background: Risk factors and screening strategies for rheumatoid arthritis-associated interstitial lung disease (RA-ILD) have received limited evaluation in patients with early RA. We investigated RA-ILD prevalence, risk factors, and the...
3.
Wallace Z, Lin M, Srivatsan S, King A, Wang X, Venkat R, et al.
Semin Arthritis Rheum
. 2025 Feb;
71:152657.
PMID: 39965512
Background: People with inflammatory arthritis are at risk for poor COVID-19 outcomes. Little is known about the impact of long COVID on disease activity, disability, and quality of life in...
4.
Wang L, Novoa-Laurentiev J, Cook C, Srivatsan S, Hua Y, Yang J, et al.
Int J Med Inform
. 2025 Jan;
196:105797.
PMID: 39864108
Background: ANCA-associated vasculitis (AAV) is a rare but serious disease. Traditional case-identification methods using claims data can be time-intensive and may miss important subgroups. We hypothesized that a deep learning...
5.
Crawford J, Penberthy L, Pinto L, Althoff K, Assimon M, Cohen O, et al.
Open Forum Infect Dis
. 2025 Jan;
12(1):ofaf021.
PMID: 39850579
Background: We developed a United States-based real-world data resource to better understand the continued impact of the coronavirus disease 2019 (COVID-19) pandemic on immunocompromised patients, who are typically underrepresented in...
6.
Hendrickson M, Parakh A, Weber B, Cook C, Ahola C, Hedgire S, et al.
RMD Open
. 2025 Jan;
11(1.
PMID: 39762122
Background: Cardiovascular disease (CVD) is a leading cause of death in ANCA-associated vasculitis (AAV). Screening and primary cardiovascular prevention may improve outcomes. Methods: We identified patients in the 2002-2019 Mass...
7.
Katz G, Cook C, Fu X, King A, Stone J, Choi H, et al.
Semin Arthritis Rheum
. 2024 Dec;
70:152609.
PMID: 39733485
Objectives: Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) face excess mortality compared with the general population. Mortality in clinical epidemiology research is often examined using death certificate diagnosis codes;...
8.
Odler B, Riedl R, Geetha D, Szpirt W, Hawley C, Uchida L, et al.
Kidney Int
. 2024 Dec;
107(3):558-567.
PMID: 39708998
Therapeutic plasma exchange (PLEX) is an adjunctive treatment for patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis and kidney involvement. Little is known about the effect of PLEX on early changes...
9.
Hendrickson M, Wallace Z
Arterioscler Thromb Vasc Biol
. 2024 Nov;
45(1):3-10.
PMID: 39569518
Vascular inflammation is a hallmark of both primary systemic vasculitis and atherosclerosis. As such, cardiovascular events are common in patients with vasculitis and likely due to both direct vascular inflammation...
10.
Tawakol A, Weber B, Osborne M, Matza M, Baliyan V, Arevalo Molina A, et al.
Circ Cardiovasc Imaging
. 2024 Nov;
17(11):e015982.
PMID: 39561226
Large vessel vasculitides (LVV) comprise a group of inflammatory disorders that involve the large arteries, such as the aorta and its primary branches. The cause of LVV is often rheumatologic...